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Abstract
Background
Cervical cancer is a major public health problem. Even though readily preventable, it is the
fourth leading cause of death in women globally. Women living with HIV are at increased
risk of invasive cervical cancer, highlighting the need for access to screening and treatment
for this population. Integration of services has been proposed as an effective way of improv-
ing access to cervical cancer screening especially in areas of high HIV prevalence as well
as lower resourced settings. This paper presents the results of a systematic review of pro-
grams integrating cervical cancer and HIV services globally, including feasibility, acceptabil-
ity, clinical outcomes and facilitators for service delivery.
Methods
This is part of a larger systematic review on integration of services for HIV and non-commu-
nicable diseases. To be considered for inclusion studies had to report on programs to inte-
grate cervical cancer and HIV services at the level of service delivery. We searched multiple
databases including Global Health, Medline and Embase from inception until December
2015. Articles were screened independently by two reviewers for inclusion and data were
extracted and assessed for risk of bias.
Main results
11,057 records were identified initially. 7,616 articles were screened by title and abstract for
inclusion. A total of 21 papers reporting interventions integrating cervical cancer care and
HIV services met the criteria for inclusion. All but one study described integration of cervical
cancer screening services into existing HIV services. Most programs also offered treatment
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of minor lesions, a ‘screen-and-treat’ approach, with some also offering treatment of larger
lesions within the same visit. Three distinct models of integration were identified. One model
described integration within the same clinic through training of existing staff. Another model
described integration through co-location of services, with the third model describing pro-
grams of integration through complex coordination across the care pathway. The studies
suggested that integration of cervical cancer services with HIV services using all models
was feasible and acceptable to patients. However, several barriers were reported, including
high loss to follow up for further treatment, limited human-resources, and logistical and
chain management support. Using visual screening methods can facilitate screening and
treatment of minor to larger lesions in a single ‘screen-and-treat’ visit. Complex integration
in a single-visit was shown to reduce loss to follow up. The use of existing health infrastruc-
ture and funding together with comprehensive staff training and supervision, community
engagement and digital technology were some of the many other facilitators for integration
reported across models.
Conclusions
This review shows that integration of cervical cancer screening and treatment with HIV ser-
vices using different models of service delivery is feasible as well as acceptable to women
living with HIV. However, the descriptive nature of most papers and lack of data on the effect
on long-term outcomes for HIV or cervical cancer limits the inference on the effectiveness of
the integrated programs. There is a need for strengthening of health systems across the
care continuum and for high quality studies evaluating the effect of integration on HIV as
well as on cervical cancer outcomes.
Introduction
Cervical cancer is a public health priority in many parts of the world and remains among the
leading causes of cancer in women. Most (85%) cases occur in low-income countries [1] and,
in 2012, 90% of deaths were in low- and middle-income countries [2]. Most of these deaths
could have been prevented through universal access to comprehensive cervical cancer preven-
tion and control programs [2]. Indeed, screening and treatment of pre-cancerous lesions to
prevent cervical cancer is one of the World Health Organization’s ‘best buys’ for the preven-
tion and control of non-communicable diseases [3].
Women living with HIV have higher risk of invasive cervical cancer, reflecting both immu-
nosuppression caused by HIV infection and shared risk factors [4]. They also have higher
prevalence of persistent HPV infection, the primary cause of cervical cancer [5] compared
with those HIV negative [6]. The natural history of HPV infection has a slow, 10–20 year pro-
gression to pre-cancer in immunocompetent women; however, women living with HIV prog-
ress more frequently and quickly to pre-cancer and cancer [2].
There are large inequities in access to effective cervical cancer screening and treatment,
with corresponding differences in the risk of invasive disease [2], with screening coverage in
low- and middle-income countries only 19% overall, but much lower in some (e.g. 1% in Ban-
gladesh) [7].
Cervical cancer screening requires a reliable health infrastructure for implementation, sus-
tainability and achievement of coverage of more than 70–80% to be effective [8]. Even though
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the number of new HIV infections is decreasing in most populations, it remains a major threat
amongst vulnerable groups worldwide and particularly in parts of Africa; nearly half of new
HIV infections occur among people living in Nigeria, South Africa and Uganda, where HIV
and AIDS constitute the number one cause of life-years lost [9]. Consequently, many countries
are now coping with the dual burden of HIV and cervical cancer [10].
Given the efficacy of antiretroviral treatment, the increased risk of cervical cancer among
women living with HIV, and the low access to screening in several countries with high HIV
prevalence, improved systems for screening and treatment are needed [11]. The World Health
Organization’s guidelines for cervical cancer control recommends cervical cancer screening as
soon as girls or women are tested positive for HIV, regardless of age, using visual inspection
with acetic acid (VIA), HPV test or cytology depending on available resources, and cryother-
apy and loop electrosurgical procedure (LEEP) for treatments [2, 12]. Moreover, inclusion of
HIV counselling and testing (HCT) into cervical cancer screening programs, and vice versa, is
recommended for all countries with high HIV prevalence, together with special efforts to
reach vulnerable populations, such as women living with HIV [2]. Yet although integration is
intuitively appealing, relatively little is known about the models of integration and factors that
facilitate or hinder integration in different contexts.
Low-cost screening techniques, such as VIA and cryotherapy, have been proposed for
women living with HIV in low-resource settings [13]. However, to our knowledge there is no
systematic review of integration of cervical cancer screening with HIV care. To address this
gap, we systematically reviewed the literature describing and evaluating interventions that
sought to integrate cervical cancer screening and treatment with HIV, reporting outcomes
where available, concluding with recommendations for future research and policies.
Methods
Definitions
We followed PRISMA guidelines [14] as part of a larger systematic review on integration of
HIV and non-communicable diseases (See S1 Table for PRISMA checklist). Where possible
we follow the PICOS structure for study characteristics, adapted for purely descriptive studies.
Drawing on the definitions proposed by Briggs, Atun et al and Legido-Quigley et al [15–18],
the concept of integration and its key attributes are described in Box 1 [19]. We also drew on a
Box 1. Domains of integration (drawing on [19])
 Integration across disease programs (clinically related diseases)
 Integration across disease programs (clinically different diseases), for example:
■ Integration across high burden conditions (e.g. HIV, malaria, TB) to reduce
impact of co-infections
 Integration between vertical (disease-specific) and horizontal (system-wide) pro-
grams, which may involve:
■ Integration of interventions within a ‘building block’ of the health system (e.g.
integrated staff training, financial and organizational management etc.)
■ Integration across one or more building blocks of the health system (e.g. human
resource policies and governance initiatives)
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typology of integration whereby service integration involved different clinical services being
integrated using teams or multidisciplinary professionals and clinical integration involved care
being integrated into a single or coherent process within and/or across professions [20]. This
review covers populations accessing health services and healthcare workers, and interventions
integrating cervical cancer screening and/or treatment services with HIV testing and/or treat-
ment services. Compared to non-integrated services for cervical cancer screening and/or treat-
ment and HIV testing and/or treatment. Due to the descriptive nature of the review any
outcomes reported by the original studies were included, including barriers and facilitators to
the intervention.
Inclusion criteria
We included all quantitative and qualitative studies describing or evaluating a management
or organizational change policy or intervention, implemented within an existing health
system, aiming to integrate HIV and cervical cancer screening and/or treatment at service
delivery level. Services could be provided in health facilities or in the community. We did
not exclude reports based on study design; nor did we require them to include outcome
measures. We imposed no language, publication date, or publication status restrictions.
Conference abstracts were included as they are an important source of unpublished studies.
No studies were excluded based on assessment of bias.
Search strategy
The search strategy and terms were developed collaboratively with an information specialist,
and were consistent with methods adopted by other authors who have conducted systematic
reviews on health services integration [15, 16]. The following electronic databases were
searched from inception until February 2014: Global Health, Medline and Embase. Key words
(MeSH terms) and free text terms were developed for 3 themes: HIV, integration and chronic
diseases and then combined in the search strategy, after which the papers on integration of
HIV and cervical cancer were identified. The search terms used for Medline are shown in
Box 2. In addition, we searched the following databases using a simplified search strategy to
ensure maximum yield of papers from low and middle income countries: Cochrane library,
LILACs, Africa Wide, WHOLIS and abstracts from the International AIDS Society (IAS)
Online Resource Library from 2006 to 2015, the HIV Implementers meetings from 2007 to
2012 and International conferences on non-communicable diseases. We conducted an
■ Integration across ‘service functions’: of inputs, of different levels of service
delivery, of management and operational decisions and technology
 Integration across public health programs and health service interventions, for
example:
■ Integration between MNCH, family planning, through trained community
health workers, and health promotion.
 Integration across activities in the health systems and other sectors (e.g. treatment
combined with educational interventions and community mobilization)
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updated search until December 2015 using Global Health, Medline and Embase and references
of included papers were searched manually.
Search and retrieval of studies
Two reviewers independently reviewed the list of articles retrieved by the electronic database
search, based on title or title and abstract, to identify those meeting the inclusion criteria. If
either of the two reviewers considered a study potentially eligible, the full text of this article
was retrieved for further assessment. There were no studies identified in languages other than
English. The retrieved full texts were assessed independently for inclusion by two reviewers.
Disagreements were resolved in discussion with a third reviewer.
Data synthesis
Two reviewers independently extracted data from included studies using standardized forms.
Differences in data extraction or interpretation of studies were resolved by discussion and con-
sensus. We extracted data from the results and discussion sections of both quantitative and
qualitative studies including information on: (1) study characteristics including study design,
setting and sample size, (2) participants characteristics including age, gender, ethnicity and
country of origin, (3) integration activities of the program or intervention, (4) results and type
of outcome measure including clinical, procedural and behavioral outcomes, and (5) the facili-
tators and barriers to integration activities as discussed in each study. The data were compared
across studies and any conflicting findings noted and, where possible, explained. We con-
ducted a narrative synthesis of the findings. Studies covering the three different models are
summarized and presented in the following sections and illustrated in more details using
examples from some of the more complex studies for each model.
Risk of bias assessment
Studies which presented evaluative rather than purely descriptive data were independently
assessed by two reviewers for risk of bias using the Cochrane risk of bias tool for randomized
Box 2. Search Strategy used for Medline, Embase and Global
Health via Ovid (adapted to only include cervical cancer terms)
Database: Embase <1980 to December 2015>, Global Health<1910 to December
2015>, Ovid MEDLINE(R) <1946 to December 2015>
1. ((vertical or horizontal or integrat or coordinat or co-ordinat or link) and
(program or care or service)).mp. or delivery of health care, integrated/ or primary
healthcare/
2. exp HIV infections/ or HIV.mp. or Human immunodeficiency virus.mp. or "HIV/
aids".mp.
3. (All introduced in a separate line) chronic disease/ or long-term care/ or ((chronic
or persistent or long term or ongoing or degenerative) adj3 (disease or disab or ill
or condition or health condition or medical condition)).tw. or long term care.tw.
or (non-communicable disease or NCD).tw. or exp neoplasms or (cancer or
oncolog or neoplasm or carcinom or tumo?r or malignan or cervical cancer).tw.
4. 1 and 2 and 3
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studies[21] and a simple pro-forma for observational studies with three domains: selection
bias, information bias (differential misclassification and non-differential misclassification) and
confounding. Each domain was assessed as low, unclear or high. Studies were considered eval-
uative only if there was an alternative group with which to compare the integration interven-
tion. We classified studies that had a low risk of bias in all domains as having a low overall risk
of bias. Studies that had a high or unclear risk of bias in one or more domains were classified
as having an overall high or unclear risk of bias.
Results
11,057 records were identified through database searching. 7,616 articles, remaining after
exclusion of duplicates, were screened by title and abstract for inclusion. 340 papers involved
one or more NCDs. After screening of the full papers 155 articles were included in total (S1
Fig). 21 of these articles, representing 23 studies, covered integration of HIV and cervical can-
cer and were included in this review (S1 Fig). All were in English. Five of the studies were con-
ference presentations [22–26]. Due to the heterogeneity in study designs, intervention types,
participants, and outcomes, we did not conduct a meta-analysis but instead present a summary
of the articles, and a synthesis of their results and outcomes where available.
Characteristics of included studies
Of the 23 included studies, 15 were cross-sectional, four were cohort studies, three were retro-
spective record reviews, and one was a before and after study. 17 studies were set in Africa,
four in South America, one in Asia and one in Europe (S2 Fig). Most were conducted in
lower-middle-income countries (n = 9), followed by low-income countries (n = 7), and upper-
middle-income (n = 6), with only one study from a World Bank classified higher-income
country [27]. 2 displays a geographical representation of the models reported. Almost all arti-
cles described the introduction of new services that a health facility had not previously offered;
only one study assessed the integration of existing services. [28] All but one study described
integration of cervical cancer screening, with or without treatment, into existing HIV services.
One described integration of HIV screening into an existing cervical cancer screening service.
[29] Several studies described the cervical cancer services offered in detail, but none described
the HIV care offered or outcomes besides HIV screening. Eight programs included only
women living with HIV [4, 24, 28, 30–33] only, the others including all women accessing the
clinics.
Models of integration
Three models of integrated care were identified, based on descriptions of services provided.
The first was within-clinic integration using internal staff. In this model, the existing clinic
structure and staff was used to incorporate a new set of services to complement services that
are already provided. In a second model, integration was achieved through co-location. HIV
and cervical cancer services were provided to the patient through coordination of care between
different specialists or clinics within the same health care facility. The third model involved
complex programs of integration and coordination, including programs that integrated ser-
vices by involving a range of different types of health workers (often from community health
workers to clinical specialists) and facilities, and established systems to ensure clinical coordi-
nation and follow-up of patients (S3 Fig). In all three models, we found different intensities of
services being provided, from cervical cancer screening only to screening and treatment of
minor to larger lesions (Table 1).
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Model 1: Within-clinic integration using existing staff
This model was described in nine papers covering 11 studies describing integration of cervical
cancer screening and different levels of treatment, into existing clinics providing HIV services.
The integration and services offered are described in Table 2. Most programs (n = 10) were set
in low-resource settings. Only two of the studies formally evaluated integration [30, 34]. Four
studies briefly described additional integration of gynecology, sexually transmitted diseases
(STDs) and/or family planning [5, 28, 30, 35]. In nine studies, the main clinical outcomes were
reported as numbers screened for cervical cancer. Four reported proportions screened (rang-
ing from 67–87%) and nine reported cervical cancer screening results (Table 3). Three studies
reported high loss to follow up for referrals or annual follow-up appointments [5, 26, 28].
None of the studies described the HIV services offered and none presented clinical HIV out-
comes. Three studies reported uptake of STD screening [28, 33, 35].
Table 1. Type of integration and cervical cancer services provided. The table shows the integration models described in the included studies.
Integration model CaCx Services CaCx methods Setting Author and Country
Within clinic integration using
internal staff
CaCx screening VIA HIV clinics • Morgan 2014 [Guyana]
PAP HIV / ID clinics • Sirivongrangson 2007*
[Thailand]
GUM clinic • Ibrahim 2013 [England]
CaCx ‘screen and
treat’ minor lesions
VIA + Cryotherapy HIV clinics • Ekong 2013 [Uganda]
Family planning clinics • Moon 2012 [Mozambique]
Mobile HIV clinics • Mulenga 2012 [Zambia]
CaCx ‘screen and
treat’ larger lesions
VIA + Cryotherapy
+ LEEP
HIV clinics and RCH clinics • Anderson 2015 [Coˆte d’Ivoire,
Guyana, and Tanzania]
• Martin 2014 [Guyana]^
HIV clinics • Huchko 2011 [Kenya]
Coordination between co-
located clinics/specialists
CaCx screening VIA HIV clinic and RCH clinic • Odafe 2013 [Nigeria]
ART and blood giving clinics • Horo 2012 [Coˆte d’Ivoire]**
PAP+ colposcopy HIV/ID clinic • Fink 2012 [Argentina]
CaCx ‘screen and
treat’ minor lesions
VIA + Cryotherapy Cervical Cancer Prevention
Program clinics in HIV clinics
• Mwanahamuntu 2013 [Zambia]
***
• Ramogola-Masire 2012
[Botswana]
Public health clinics • Parham 2010 [Zambia]***
CaCx ‘screen and
treat’ larger lesions
Complex program of
integration and coordination
CaCx screening PAP HIV / ID clinics • McCree-Hale 2011 [Tanzania]
CaCx ‘screen and
treat’ minor lesions
VIA + Cryotherapy Family planning, and child and
maternal health clinics
• Khozaim 2014 (Kenya)
• Plotkin 2014 [Tanzania]
CaCx ‘screen and
treat’ larger lesions
VIA + Cryotherapy
+ LEEP
HIV clinics and/or Public health
clinics
• Mungo 2013 [Kenya]
• Pfaendler [Zambia]
• Shiferaw,2016 [Ethiopia]^^
^LEEP available in two of the 18 sites
^^LEEP available at some of the sites or by referral
*PAP and HPV testing
**VIA and VILI
***VIA and digital camera
CaCx: cervical cancer, VIA: visual inspection with acetic acid, PAP: Papanicolaou test, ID: infectious diseases, GUM: genitourinary medicine, LEEP: loop
electrosurgical excision procedure, RCH: reproductive and child health.
https://doi.org/10.1371/journal.pone.0181156.t001
Integrating cervical cancer with HIV healthcare services
PLOS ONE | https://doi.org/10.1371/journal.pone.0181156 July 21, 2017 7 / 26
Table 2. Model 1—Within clinic integration using internal staff.
Study Study design Setting Model of care Integration Screening
n (% of
those
offered)
HIV
positive
Treatment
coverage
Selection
bias
Morgan 2014 Cross-
sectional
The National
Care and
Treatment referral
centre (NCTC),
Guyana
Single-site
approach: VIA
screening
VIA provided as a
baseline test for all
HIV positive
women and
reinforced by
NCTC health
team, which also
promotes annual
VIA screening.
Also extends to all
women.
1,831 49% NA: Screening
only
N/A
Sirivongrangson
2007
Cross-
sectional
An urban
infectious disease
clinic and an STI
clinic, Thailand
Screening: Pap
test, HPV DNA
test, and
screening and
treatment of
STIs. Referral of
those with
abnormal
cervical cytology.
HIV-infected
women attending
either an infectious
disease clinic or a
STI clinic were
screened.
150 (70.8%)
at infectious
disease
clinic and 60
(100%) at
the STI
clinic.
100% NA: Screening
only
N/A
Ibrahim 2013 Retrospective
record review
A hospital
genitourinary
medicine
department, the
UK
Screening using
smear test and
cytology.
Referred for
colposcopy
according to local
and national
guidelines.
CaCx screening
integrated into a
genitourinary
medicine clinic for
HIV positive
women.
101 (78%) 100% Following the initial
smear, all women
were appropriately
followed up with
annual cytology or
referred for
colposcopy
according to local
and national
guidelines. 22
patients were lost
to follow-up after
initial cytology.
N/A
Ekong 2013 Retrospective
record review
Five rural ART
clinics, Uganda
‘See and Treat’:
VIA and
cryotherapy,
advanced cases
referred.
Existing
healthcare
workers trained to
provide CaCx
services.
1,088 19% 53.6% (15/28)
HIV-positive and
VIA-positive
women were
treated with
cryotherapy;
46.4% were
referred.
N/A
Moon 2012 Cross-
sectional
Four rural family
planning health
facilities and one
referral hospital,
Mozambique
‘See and Treat’:
VIA and
cryotherapy,
advanced cases
referred. LEEP
and surgery were
provided at the
provincial
hospital for
serious cases.
CaCx screening,
family planning,
HIV VCT, and STI
and gynecological
screening all
performed during
one visit in the
same physical
space. Technical
assistance
infrastructure of a
HIV program used
to introduce CaCx
services.
4,651 12.5% 61% (221/380) of
cryotherapy
eligible women
received same day
treatment–
increasing from
53% during the
first quarter to 96%
during the last
quarter.
N/A
(Continued )
Integrating cervical cancer with HIV healthcare services
PLOS ONE | https://doi.org/10.1371/journal.pone.0181156 July 21, 2017 8 / 26
Table 2. (Continued)
Study Study design Setting Model of care Integration Screening
n (% of
those
offered)
HIV
positive
Treatment
coverage
Selection
bias
Mulenga 2012 Cross-
sectional
14 Zambia
Defense Force
mobile HIV VCT
service units,
Zambia
‘See and Treat’:
VIA and
cryotherapy,
advanced cases
referred.
Screening
provided on an
opt-out bases to
women accessing
mobile HIV VCT
services.
560 (67%) 20% 11% (62/560) were
eligible for onsite
cryotherapy and
were treated
immediately, while
5% (26/560) were
referred, of these
92% (24/26)
completed the
referral.
N/A
Anderson 2015 Cross-
sectional
24 HIV clinics and
23 reproductive
and child health
clinics in national,
regional, and
district hospitals,
and health
centers, Coˆte
d’Ivoire, Guyana,
and Tanzania
‘See and Treat’:
VIA and
cryotherapy,
ineligible referred
for LEEP,
advanced cases
referred.
Existing
healthcare
workers trained to
provide CaCx
services. Shared
training protocols
and multiple types
of staff involved.
34,921 26% 85% (2,508) of
eligible women
received
cryotherapy during
the same visit; only
234 (52%) of those
who postponed
returned for
treatment; 622
(17%) VIA-positive
women were
referred for
excisional
treatment.
N/A
Martin 2014 Retrospective
record review
18 CaCx
prevention sites,
including 10 HIV
care and
treatment sites,
Guyana
‘See and Treat’:
VIA and
cryotherapy,
ineligible referred
for LEEP,
advanced cases
referred, referred
patients followed
up. Counselling
and education.
Physicians and
non-physicians
trained to provide
CaCx screening
services.
Development of
treatment
guidelines with
Ministry of Health
and stakeholders.
21,597 8% 85% (1938) of
women eligible for
cryotherapy
received
immediate
treatment. Of the
347 women who
postponed
cryotherapy, 62%
returned for
treatment, while
38% were lost to
follow-up. Half
(1,027) of VIA
+ women treated
with cryotherapy
LEEP returned for
a 1-year follow-up
screening.
Unclear
risk of bias
Huchko 2011 Retrospective
record review
District hospital
and HIV clinics,
Kenya
VIA and
colposcopy,
LEEP treatment,
advanced cases
referred.
Outreach,
awareness, and
education
campaign.
CaCx screening
offered as part of
routine care at HIV
clinics. Full clinic
involvement and
training.
Coordination with
local experts and
external
pathologists.
3,642 (87%) 100% 531 (15%)
underwent
colposcopy for
either positive or
unsatisfactory VIA;
243 LEEPs were
performed. Eight
women (0.1%)
were referred for
radiation therapy
or surgery.
Unclear
risk of bias
Abbreviations: VIA: visual inspection with acetic acid, NA: not applicable, STI: sexually transmitted infection, HPV: human papilloma virus, CaCx: cervical
cancer, LEEP: loop electrosurgical excision procedure, VCT: voluntary counselling and testing.
https://doi.org/10.1371/journal.pone.0181156.t002
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Table 3. Types of outcomes reported.
Type of model Patient Outcomes N Process Outcomes N
Within clinic integration Numbers offered CaCx screening 9 Proportion screened within 1 year of HIV diagnosis 1
Proportion accepting CaCx screening 4 Proportion followed up annually 2
CaCx screening results 9 Number of staff trained 3
Proportion offered cryotherapy 6 Loss to follow up 5
Proportion referred for larger lesions and
treatment
6 Screening uptake by type of clinic or region 3
Proportion offered colposcopy 3 Proportion treated with cryotherapy same day 3
Proportion taking up colposcopy 1 Complications/severe adverse events 2
Pathology results 3 VIA positive rates over time 1
Cancer diagnosis 4 Proportion of service providers offering screening over time by
type of provider
1
Reasons for declining CaCx screening 1 Proportion screened for CaCx versus national screening
program over time
1
CD4 counts 2 Staff satisfaction 1
Proportion on HAART/ART 1 Provider barriers 4
Proportion with STI 3
Perceived patient barriers 2
Proportion with high risk HPV infections/types of
HPV
1
Coordination through
colocation
Numbers offered CaCx screening 5 Loss to follow up 2
Proportion accepting CaCx screening 1 Proportion undergoing cryotherapy same day 1
CaCx screening results 5 Proportion returned for follow up 1
Proportion on HAART/ART 2 Probability model of program effectiveness 1
Proportion referred for further CaCx diagnostics or
treatment
4 Sensitivity and specificity of nurse screening assessment 1
Patient barriers for uptake of support 1
CaCx pathology results 3
Cancer diagnosis 2
Proportion CaCx screen positive at follow up
screening
1
Complex coordination Numbers offered CaCx screening 6 Loss to follow up 3
Proportion accepting CaCx screening 3 Proportion diagnosed using Colposcopy vs. LEEP 1
CaCx screening results 5 Probability model of number of cancer cases prevented 1
Proportion taking up CaCx treatment 1 Numbers screened for HIV over time 1
Proportion referred for CaCx diagnostics and
treatment
3 Proportion followed up with repeat CaCx screening over time
and outcomes
1
Proportion referred for larger CaCx lesions and
treatment
1 Hazard of recurrence of CaCx 1
CaCx pathology results 1 Proportion followed up annually 1
Cancer diagnosis 3 Proportions followed up 1
Numbers offered HIV screening 1 Proportion accepting CaCx screening by type of clinic or region 1
Proportion accepting HIV screening 1 Proportion treated with cryotherapy same day 1
Reasons for not offering HIV screening 1 Numbers screened for CaCx over time 1
Reasons for declining HIV screening 1
Complications 1
Patient barriers to uptake 3
Abbreviations: ART: Antiretroviral Therapy, CaCx: cervical cancer, HAART: Highly Active Antiretroviral Therapy, LEEP: Loop Electrosurgical Excision
Procedure, STI: sexually transmitted infections
N: The number of studies that reported this outcome, by model of integration
https://doi.org/10.1371/journal.pone.0181156.t003
Integrating cervical cancer with HIV healthcare services
PLOS ONE | https://doi.org/10.1371/journal.pone.0181156 July 21, 2017 10 / 26
A cross-sectional study from Mozambique [35] described integration of cervical cancer ser-
vices with PEPFAR-funded rural clinics and a hospital, with training of existing child health
nurses in VIA and cryotherapy. Women were offered cervical cancer screening together with
screening for STDs and gynecology pathologies in a single visit. Prior to integration, there was
no access to cervical cancer screening. The service screened twice as many women in the first
year (n = 4,651, 13% HIV+) for cervical cancer than envisaged in the Ministry of Health target.
The VIA+ rate was 8% (n = 380). 61% of VIA+ women underwent cryotherapy the same day
and 4% required referral. By the end of the year, 96% were receiving treatment the same day,
without any adverse events. 5% (n = 218) of women were diagnosed clinically with STIs; 98%
(n = 214) received treatment.
Another cross-sectional study evaluated the integration of ‘screen-and-treat’ cervical cancer
services in 24 HIV and 23 reproductive and child health clinics (RCHCs) in Cote d’ Ivoire,
Guyana and Tanzania with training of existing staff in cervical cancer screening and treatment.
The integrated services screened>34,000 women for cervical cancer (2009–2012). [5] 10%
(n = 3,580) of women screened were VIA+ and 85% (n = 2,508) of eligible women received
cryotherapy during the same visit. Immediate treatment of small-to-large lesions in a single-
visit reduced loss to follow up. In contrast, only 52% (n = 234) of women who postponed treat-
ment returned. In multivariate analysis, controlling for a range of factors, women living with
HIV had higher odds of being VIA+ (OR 1.95, 95% CI 1.76, 2.16, P<0.0001) and of having
large lesions requiring referral (OR 1.93, 95% CI 1.49, 2.51, P< 0.0001) compared to HIV-
women. The risk of complications was<1%.
A cross-sectional study set in Zambia[26] evaluated uptake of a new cervical cancer screen-
ing and treatment integrated into mobile outreach vans delivering HIV screening and support.
The authors reported a 67% uptake (n = 560, 20% were HIV+); 16% (n = 88) had abnormal
cervical lesions. 11% (n = 62) screened and eligible for cryotherapy underwent immediate
treatment. 5% (n = 26) were referred for treatment of larger lesions of which 92% (n = 24)
completed the referral.
Model 2: Coordination through co-location clinics/specialties
Six papers described this model of integration (Table 4); five programs were set in Africa [4,
31, 36–38], and one in South America [23]. Five of the studies described integration through
co-location of cervical cancer and HIV clinics; one program used a model based on mobile
gynecologists who provided weekly cervical cancer services in HIV clinics. Most studies pre-
sented data on numbers of women screened for cervical cancer, one reported the proportion
accepting screening, and five studies reported screening results. Two studies reported cancer
diagnoses. Two studies reported high loss to follow up,[36, 38] with one reporting higher rates
amongst women living with HIV compared to HIV-negative women and a reduction in loss to
follow up (20% vs. 37%) when using a mobile phone tracking and recall system. [36]
Mwanahamuntu et al., presented the results from a cross-sectional study set in Zambia
[39]. They evaluated the integration of new cervical cancer screening clinics into 17 public sec-
tor health clinics and a surgical center in Zambia, which delivered PEPFAR sponsored HIV
care and treatment services at the same sites. HIV screening was also integrated into the cervi-
cal cancer clinics for women with unknown HIV status. These mutual linkages achieved
greater efficiencies. Nurses were trained in cervical cancer screening and treatment of minor
lesions. Digital images were used as an adjunct to screening and reviewed weekly with a gyne-
cologist. For sustainability, peer educators were used for health promotion and as patient
navigators to reduce loss to follow up, and the program was constantly refined through com-
munity feedback. Task-shifting helped overcome workforce shortages. The program screened
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Table 4. Model 2—Coordination between co-located clinics/specialists.
Study Study
design
Setting Model of care Integration Screening
n (% of
those
offered)
HIV
positive
Treatment coverage Selection
bias
Odafe 2013 Cross-
sectional
Secondary
healthcare urban
public hospital,
Nigeria
All women attending
ART were counselled
on CaCx screening,
those accepting were
referred to the
reproductive health unit
for same-day VIA
screening. Referred for
colposcopy and
treatment.
Coordination
between ART unit
and reproductive
health unit with bi-
directional referral
and patient tracking
system.
834
(96.5%)
100% NA: Screening only N/A
Horo 2012 Case
-control
with sub-
cohort
Three ART clinics
and a blood donor
clinic, Cote d’Ivoire
Screening by mobile
staff, referred for
colposcopy if positive or
inconclusive at ART
clinic, follow-up and
treatment at ART clinic.
Coordination
between mobile staff
and the ART clinic to
provide screening
and treatment for
CaCx.
4,046 74% 414 referred for
colposcopy, 36.5%
(n = 151) did not attend.
A systematic mobile
phone tracking system
reduced the loss to
follow up from 36.5% to
19.8%.
N/A
Fink 2012 Cross-
sectional
A hospital HIV
clinic, Argentina
Screening: Pap smear
and colposcopy
New weekly specific
clinic for women
living with HIV; care
provided by HIV and
gynecological
specialists.
96 100% NA: Screening only N/A
Mwanahamuntu
2013
Cross-
sectional
17 clinics and an
outpatient surgery
care center
housing a
Gynecologic
Cancer Prevention
Clinic, Zambia
‘See and Treat’: VIA
and cryotherapy, refer
cryotherapy-ineligible
for evaluation and
treatment to an
outpatient surgery clinic
located in a tertiary
hospital.
Physical co-location
of CaCx program
clinics with HIV/
AIDS clinics.
56,427 26.7% Not reported N/A
Ramogola-
Masire 2012
Cross-
sectional
Community and
hospital-based
HIV clinics,
Botswana
“See and Treat”: VIA
and EDI and
cryotherapy.
Cryotherapy ineligible
referred for colposcopy/
LEEP to local hospital.
Complex lesions
referred to specialized
clinic, advanced cases
referred to tertiary
hospital.
Coordination
between HIV clinic
and CaCx screening
community clinic in
the same facility.
2,175 100% 253 received same-day
cryotherapy. 575 were
referred for further
evaluation and
treatment. 61.3%
women received
appropriate same-day
screening and treatment
without the need for
recall or referral.
N/A
Parham 2010 Cohort 11 urban and four
rural public health
clinics, Zambia
“See and Treat”: VIA
and cryotherapy,
referred for histologic
evaluation and clinical
management. Follow-
up visits for those
undergoing cryotherapy
or LEEP are
encouraged at 6 weeks
and 6 and 12 months.
Specialist nurses
coordinate care
independently in
rooms co-located
within 15 public
health clinics.
21,010 31.3% Of the women eligible
for ablative treatment by
cryotherapy, 78%
(1603/2061) actually
underwent treatment. A
total of 75% (1095/
1462) of HIV-infected
women referred for
evaluation complied.
Less than 20% of
women ever returned for
their recommended
follow-up visit.
High
Abbreviations: CaCx: cervical cancer, VIA: visual inspection with acetic acid, NA: not applicable, EDI: enhanced digital imaging, LEEP: loop electrosurgical
excision procedure
https://doi.org/10.1371/journal.pone.0181156.t004
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56,427 women (27% HIV+) during the study period (2006–2011). 28% of women were VIA+.
Women living with HIV had 2.62 times higher odds of being VIA+ [AOR: 2.62 (95% CI: 2.49,
2.76, p<0.001] than HIV- women.
In another cross-sectional study, Odafe et al. evaluated a program integrating cervical can-
cer screening into existing reproductive and child health clinics co-located with HIV services
in Nigeria [4]. Nurses and midwives in both units were trained in counselling, appointment
setting and managing a bi-directional referral system. Women attending the HIV service were
offered same day cervical cancer screening in the reproductive and child health clinic, and
women with unknown HIV status referred for HIV testing. The program also offered screen-
ing for STDs. Electronic health record systems were created to support the referral program.
The uptake of cervical cancer screening amongst women living with HIV (2009–2010) was
96.5% (n = 805/834). 7% (n = 52) were VIA+, 25% (n = 199) were diagnosed with an STD.
Three of the papers reporting this model described the use of digital images as adjunctive to
the cervical cancer treatment, as a tool to improve training and quality [31, 38, 39]. The images
were reviewed by gynecologists either remotely or in weekly sessions, together with the nurses.
One of the studies, a cross-sectional study evaluating an integrated service in Botswana [31],
found that 20% of women initially diagnosed with normal VIA results were recalled for assess-
ment after the image review, finding 75.3% (95% CI, 72.5–77.8%) sensitivity of the nurse
assessment and a 98.5% (95% CI, 97.6–99.1%) specificity.
Model 3: Complex program of integration and coordination
Six studies, all set in Africa (Table 5), presented complex programs of integration of cervical
cancer with HIV services with coordination across care pathways. A majority described
integration of cervical cancer services into existing clinics providing HIV care. One study
described the integration of HIV services into existing cervical cancer clinics [29]. All studies
reported data on numbers of women screened for cervical cancer, three reported screening
uptake as proportion of women offered cervical screening and five studies reported clinical
screening results (Table 5). Three studies presented final cancer diagnoses. Only one study
reported HIV-related measures, including uptake of HIV testing, HIV sero-positivity, and rea-
sons for declining screening or not offering screening.
A cross-sectional study evaluating integration of HIV screening into 21 government health
facilities providing cervical cancer services in Tanzania showed a good uptake of screening for
both HIV and cervical cancer. [29] Nearly 25,000 women were screened for cervical cancer
(2010–2013) and 60% of women with unknown HIV status offered HIV testing; 94% accepted
and 5% tested positive. Limited access to HIV test kits was the main reason that not all women
were offered HIV screening. The authors concluded that integrating HIV testing into cervical
cancer screening facilities was acceptable to staff and patients and an effective way of reaching
women with unknown HIV status. However, they also acknowledged that more support was
needed to reduce logistical barriers, such as access to test kits and equipment.
A cohort study set in Ethiopia [32] analyzed the integration of VIA and cryotherapy in a
single visit approach in 14 established secondary and tertiary health centers which offered HIV
services. The program trained 77 health care workers (physicians, nurses, and midwives). To
support the training, basic clinical and counselling guides, single visit standard operating pro-
cedures and quality management toolkits were provided. To ensure staff skills, bi-annual
refresher training and quarterly visits were conducted using competence checklists. The pro-
gram was feasible and acceptable to patients, as shown by high uptake of screening (99%) and
98% of eligible women received cryotherapy the same day. There was, however, high loss to
follow up; the treatment rate for women referred for LEEP was only 63%. Moreover, only 51%
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Table 5. Model 3—Complex program of integration and coordination described.
Study Study type Setting Model of care Integration Screening n
(% of those
offered)
HIV
positive
Treatment coverage Selection
bias
McCree-
Hale 2011
Case series Urban HIV clinics,
Tanzania
HIV clinics provide
Pap smear
screening, slides
sent to lab in
external hospital,
follow-up and
treatment at
national cancer
center.
CaCx screening
integrated into HIV a
clinics, using existing
staff. Coordination
with external center
and lay health
workers to ensure
follow-up of care.
1,440 100% Of the 124 women
with SIL, 5 (4%)
presented for follow
up and treatment at
the national cancer
center. The
remaining 119
women had to be
tracked using a
district tracking
mechanism
comprised of trained
lay health workers.
N/A
Khozaim
2014
Retrospective
descriptive
study
Four regional HIV
clinics and child-
maternal clinics,
Kenya
‘See and Treat’: VIA
and cryotherapy.
Cryotherapy-
ineligible evaluated
by local
gynecologists at
mobile colposcopy
service rotating
once a month per
site, biopsies
evaluated at referral
hospital and results
reviewed by
gynecologists at the
clinics, referred for
LEEP.
Integration of a public
sector CaCx
screening program
into existing large HIV
clinics. MoH working
with NGO to train
local staff and
implement system of
care across 4 regions.
The collaboration
provide logistic
support, supply chain
management, and
screening rooms.
6,787 NA 206 women
underwent
cryotherapy, 754
colposcopy, 143
LEEP, and 27
hysterectomy. The
overall loss to follow-
up was 31.5%:
27.9% were lost after
a positive VIA
screen, 49.3%
between biopsy and
LEEP, and 59.6%
between biopsy and
hysterectomy/
chemotherapy.
N/A
Plotkin
2014
Cross-sectional Government
health facilities:
The national
consultant referral
hospital, two
regional hospitals,
twelve district
hospitals, and six
health centers,
Tanzania
HIV: HIV testing
offered to all women
unless they were
HIV positive or (self)
reported being
tested in the last
three months. If test
positive, referred to
the onsite HIV CTC.
CaCx: “See and
Treat”: VIA and
cryotherapy,
advanced cases
referred. Three the
facilities also offered
LEEP for treatment
of large lesions.
Integration of HIV
testing within newly
introduced CaCx
screening and
treatment services,
located in the
reproductive and child
health (RCH) section
of the facility.
Coordinated referral
between RCH and
HIV CTC. Part of the
Government National
Strategy for CaCx
prevention.
24,966 for
CaCx;
11,819
(94%) for
HIV
NA NA: Screening/
testing only
Low/
unclear
Mungo
2013
Retrospective
record review-
before and after
study
Family AIDS Care
and Education
Services HIV
clinic, Kenya
VIA and
colposcopy, LEEP
treatment,
advanced cases
referred. Women
treated with LEEP
were re-screened
with colposcopy at
6, 12, and 24
months, and those
with CIN 2, CIN 2/3,
or stage IA1 disease
during follow-up
were offered repeat
LEEP.
Addition of LEEP
treatment to CaCx
screening services at
a HIV clinic.
Coordination with
external pathologist to
interpret biopsies, in-
clinic gynecologist for
clinical staging, and
external hospitals for
treatment.
4,308 100% 100% (39/39) stage
IA1 patients and
95.1% (39/41) of all
women with ICC
accessed treatment.
High
(Continued)
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(range: 30%-81% by regions) of VIA+ women returned for 1-year follow up. The proportion
of eligible HIV positive women receiving treatment for major lesions varied by region from
4.8% to 86.7% suggesting inconsistent quality of service provision among providers or other
variables which might have impeded access.
A retrospective descriptive study evaluated the integration of a public section cervical can-
cer screening program into HIV and family health clinics in Kenya. [40] This screened 6,787
women (2009–2011), finding 20% (n = 1331) VIA+ and 71% (n = 949) HIV+. 68 women had
cancer, with an incidence of 414 per 100 000 women per year. The authors estimated that the
screen-and-treat model, averted 349 cases from progressing to cancer. However, the loss to fol-
low up was high (32%), and increased as treatment became more invasive. 28% were lost after
a VIA+ screen, 49% between biopsy and LEEP and 60% between biopsy and hysterectomy/
chemotherapy.
Outcomes reported
Many studies described measures of clinical process and outcomes, with a majority presenting
numbers of women screened for cervical cancer during the study period and some reporting
Table 5. (Continued)
Study Study type Setting Model of care Integration Screening n
(% of those
offered)
HIV
positive
Treatment coverage Selection
bias
Pfaendler
2009
Cross-sectional 13 primary care
clinics and a
tertiary care
hospital, Zambia
‘See and Treat’: VIA
and cryotherapy.
Referral of patients
for further
evaluation: repeat
VIA and punch
biopsy or LEEP,
with 6-week follow-
up. Further referral
as necessary.
Implementation of a
referral and
management system
for cryotherapy-
ineligible women
needing further
evaluation. HIV peer
educators, HIV CTC
staff, and nurses
engaged in
community
awareness for CaCx
screening among
HIV-positive women.
8,823 41.5% 2,378 women were
treated with
cryotherapy and
1,477 were referred.
59.2% (875) of
women referred kept
their appointments.
748 women
underwent LEEP.
N/A
Shiferaw
2016
Cohort 14 tertiary and
secondary-level
health facilities (5
allocated as
Centers of
Excellence),
Ethiopia
‘See and Treat’: VIA
and cryotherapy,
ineligible referred
for LEEP at Centers
of Excellence.
Counselled to return
for follow-up.
Integration of CaCx
screening and
treatment into the HIV
and AIDS care and
treatment package,
establish provider
teams throughout five
regions, build
capacity, and
promoted community
education and
awareness.
Coordinated referral
and patient follow-up
between ‘see and
treat’ sites and
Centers of
Excellence.
16,632
(99.4%)
100% 96.9% (1,481) of
eligible women
received cryotherapy
on the same day as
screening; 63.0%
(80) of women
referred for LEEP
received treatment;
51.1% (614) of
women expected to
come for follow-up
returned for
screening 1 year
later and were
screened.
N/A
Abbreviations: CaCx: cervical cancer, SIL: squamous intraepithelial lesion, VIA: visual inspection with acetic acid, LEEP: loop electrosurgical excision
procedure, MoH: Ministry of Health, NGO: non-governmental organization, CTC: care and treatment centers, CIN: cervical intraepithelial neoplasia, NA: not
applicable
https://doi.org/10.1371/journal.pone.0181156.t005
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uptake as proportion of women screened (Table 3). A majority also reported cervical cancer
screening results. Only a limited number of studies followed up patients referred for treatment
and reported final cancer outcomes. Most of these studies reported high loss to follow up for
treatment, with some showing a reduction in loss to follow up through integration of treat-
ment of larger lesions in a single visit, while others achieved improved results with mobile
phone or other tracking systems. Other outcomes reported by studies, included improved
access to gynecology examinations and STD screening. Process measures included staff satis-
faction, patient acceptability and patient-perceived barriers. The reported facilitators and bar-
riers to integration of cervical cancer and HIV care are summarized in Table 6. Four papers
presented patient-perceived barriers to uptake of services including time, costs, fear of results
and wanting to consult with their spouse/partner.
Risk of bias
We screened all studies and found only five eligible for risk of bias assessment as they pre-
sented evaluative data [29, 30, 34, 38, 42]. Mungo et al. present a before and after study with
high risk of bias due to selection (no randomization, no concealment, selection of groups not
done at the same time), attrition (incomplete follow-up and outcome data), and information
bias (record review). Parham et al. also had high risk of bias. This cohort study had high loss to
follow-up and low confidence in the validity of the assumptions used for predictive values,
progression rates, and cure rates in the model (these were based on few and highly heteroge-
neous publications). Although the selection bias in Plotkin et al. appeared to be low, with all
records at the facilities being reviewed, adequate information was not provided in this cross-
sectional study to assess other forms of bias. Huchko et al. describe a cross-sectional study
and Martin et al a retrospective record review. Neither study stated the selection criteria for
women to be offered screening and Huchko et al. collected data from health records of unclear
quality.
Measures of effectiveness of integration
Five studies formally evaluated the integration of HIV and cervical cancer services (Table 7).
These included two cross-sectional studies [29, 30], two retrospective record reviews, one of
which was a retrospective record review before and after study, and a cohort study.
The before and after assessment involved the transformation of a system of cervical cancer
screening in a HIV clinic with referral for treatments to one that included on-site Loop Elec-
trosurgical Excision Procedure (LEEP) treatment within the HIV clinic and referral only of
complicated cases [42]. Addition of immediate LEEP in-clinic services increased access to
treatment (from 26.7% to 100% for women with stage IA1 disease (<3mm deep and 7mm
wide, with no spread) and from 35.5% to 95.1% for all women with invasive cervical cancer)
compared with when patients were instead referred to a local hospital. Patient preference for
the integrated in-clinic service was also described, with women living with HIV choosing to
receive LEEP treatment in the HIV clinic instead of the local hospital.
Parham et al. present a cohort study that modelled the effectiveness of their cervical cancer
prevention program in Zambia, which introduced cervical cancer screening and treatment for
women living with HIV, by estimating the total number of cervical cancer deaths prevented
[38]. They estimated that the program prevented one cervical cancer death per 46 HIV positive
women screened. It is not reported, however, whether the introduction of cervical cancer
screening and treatment, independent of integration with HIV services, would have a similar
effect on preventing death.
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A cross-sectional study looked at the proportion of cervical cancer screening clients who
were offered HIV screening through an integrated care program over time to evaluate the sus-
tainability of the integrated service [29]. Although the acceptability of HIV screening among
cervical cancer screening clients was high (94%), the proportion of clients offered HIV testing
dropped over time (from 86% in 2011 to 55% in 2013), suggesting a lack of sustainability of the
integrated screening program which could have been due to a variety of factors.
Table 6. Facilitators and barriers to integrated cervical cancer and HIV care. The tables shows barriers
and facilitators mentioned in the results or discussion.
Facilitators Barriers
Integration of the program within pre-existing
healthcare infrastructures [26, 30, 34, 35, 39–41]
Lack of staff and skilled staff [5, 29, 30, 35, 40–42]
Task-shifting [34, 35, 39] Lack of pathologists [39–41]
Evidence based cost-effective / low cost screening
[30, 35, 38–40]
Staff fatigue [34, 35, 40]
Single visit approach (”see- and-treat”) [5, 26, 30, 32,
34, 35, 40]
High staff turnover, [29, 32, 35, 41]
Qualified staff, certified nurses with some medical
training [38, 39]
Loss to follow up [24, 28, 29, 32, 35, 38–41]
Care coordinator [28] Inconsistent supply of resources, incl. supplies and
equipment [5, 29, 32, 34, 35, 39–41]
Staff willingness [30, 39] Physical infrastructure [34, 35]
Training [26, 30, 32, 34, 35, 40] Lack of medical records/electronic records [35]
Train the trainer models [22, 35, 39, 40] Long waiting times for results, delays in access to
treatment [24, 40]
Continuous education and/or supervision [22, 30, 32,
34, 35, 39, 40]
Limited treatment capacity [5]
Screening algorithms and/or protocols [30, 32, 40, 42] Lack of recall/follow up systems [5, 41]
Digital camera for training and quality improvement
[31, 38, 39]
Lack of financial incentives to providers [29]
Capacity building for health care workers [4] Inconsistent quality between providers [32]
Developing referral system [5, 42] Failure to screen for HIV /missed opportunity [35]
Bi-directional referral: HIV and reproductive health
services [4]
Patient barriers:
Electronic medical records system [4, 30] Treatment and transport cost [32, 36, 42]
Phone-based tracking/call and recall system [28, 36,
40]
Long time to wait for treatment[42]
Renovation of facilities, appropriate screening rooms
[35, 38, 40]
Long transport [5, 32]
Stakeholder engagement, community participation [4,
32, 39]
Lack of time [36]
Health promotion targeting patients [30, 32, 39, 41] Fear of cervical cancer diagnosis and treatment
[36]
Peer educators [30, 39, 41] Fear of HIV test results [29]
Low transport costs [41]
https://doi.org/10.1371/journal.pone.0181156.t006
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Table 7. Results of the studies evaluating integration.
Study Objective Setting and sample
size
Study
design
Clinical & behavioral
outcomes
Process outcomes Risk of bias
Huchko
2011
To evaluate outcomes of
cervical cancer screening
within HIV care and
treatment
District hospital and
HIV clinics in western
Kenya. n = 4,186 HIV
+ women attending the
clinics.
n = 23 clinicians
interviewed about the
program
Cross-
sectional
• Acceptability of
screening: 87% (3642) of
those offered accepted;
96% of whom accepted
screening during the
current visit.
• Accessing new
population: <1% (18)
women reported having
had screening in the past.
• Reasons for declining
screening included
“needing to talk with their
husband”, “being on their
menses”, “needing to
think about it”, and
expressing fear of the
speculum exam.
• Staff reported a high
level of satisfaction with
their training and their role
in implementing CaCx
screening in the clinic.
Main challenges reported
were related to
infrastructure limitations
and perceived patient
barriers.
• Overall: unclear
selection: unclear
• diff misclas: NA
• non-diff misclas:
unclear
• confounding: NA
Martin
2014
To evaluate a cervical
cancer prevention project
in Guyana and to identify
lessons learned to inform
the improvement of
cervical cancer
prevention programs.
Cervical cancer
prevention sites
including HIV care and
treatment sites and a
hospital across 9
regions in Guyana.
n = 21,597 women (HIV
+ and HIV-) attending
the sites.
RRR • Wide coverage of
screening: 95% (21,597) of
HIV+ women enrolled in
care and 17% of women
aged 25–49 years in
Guyana were screened.
• A smaller proportion of
HIV+ women received
immediate cryotherapy
compared to HIV
−/unknown women (73%
vs 86%; P < 0.001).
• Of those who postponed
treatment, similar
proportions returned for
cryotherapy (HIV+, 60%;
HIV−/unknown, 62%;
P = 0.73)
• At study period end, 49
(69%) trained providers
were still offering VIA,
cryotherapy and/or LEEP
services.
• Non-physician providers
were more likely to
continue providing
services than physicians
(80.5% vs 53.3%).
• Most programmatic
challenges were related to
systemic rather than
technical/ clinical issues.
• Overall: Unclear,
selection: unclear
• diff misclas: NA
• non-diff misclas:
unclear
• confounding: NA
Mungo
2013
To evaluate the effect on
treatment follow-up of
offering LEEP in-clinic
compare with by referral.
HIV clinic in western
Kenya. N = 4,308 HIV
+ women
RRR:
Before
and after
study
• Increased access to
treatment after addition of
immediate LEEP in-clinic
services [100% (39/39)
stage IA1 patients and
95.1% (39/41) of all women
with ICC accessed
treatment] compared with
referral to a local hospital
[26.7% (4/15) stage IA1
patients and 35.5% (6/17)
of all women with ICC
accessed treatment].
• When offered LEEP in-
clinic or referral for the
treatment of stage IA1
disease, all eligible
women chose LEEP
performed in-clinic at no
cost.
• Overall: high1
• selection: high
performance: NA
detection: unclear/
high, attrition: high,
reporting: unclear
Parham
2010
To analyse clinical
outcomes and modelled
program effectiveness
among HIV-infected
women by estimating the
total number of CaCx
deaths prevented
through screening and
treatment.
11 urban and 4 rural
public health clinics in
Zambia.
n = 21,010 women (HIV
+ and HIV-) attending
clinics
Cohort • One cervical cancer
death prevented per 46
(corresponding range: 28–
68) HIV-infected women
screened by the program
(142 prevented deaths
among 6572 screened).
• Overall: high
• selection: high
• diff misclas:NA
• non-diff misclas:
low
• confounding: NA
(Continued )
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Two studies, a cross-sectional one [30] and a retrospective record review [34], assessed the
process of integrating services [30, 34]. Huchko et al. used a questionnaire to ask staff about
the implementation of VIA screening and LEEP treatment services at Family AIDS Care and
Education Services clinics [30]. Staff reported a high level of satisfaction with their training
and their role in implementing cervical cancer services in the HIV clinic. The main challenges
reported were related to infrastructure limitations and perceived patient barriers (Table 6).
Martin et al. conducted an evaluation of the implementation process to assess the sustainability
of their integrated ‘screen and treat’ cervical cancer program through provider and stakeholder
interview, chart review, and service statistics [34]. They concluded that the single-visit cervical
cancer screen-and-treat program was feasible, effective and sustainable. This was based on
findings that, at the end of the study period (January 2009 to June 2012), trained providers
were still offering VIA, cryotherapy and/or LEEP services. Moreover, 95% of women living
with HIV women enrolled in care at the clinics were screened for cervical cancer and, although
a somewhat lower proportion of HIV-positive compared with HIV-negative women received
treatment (73% immediate and 60% postponed versus 86% immediate and 62% postponed),
overall treatment coverage was high. The study also found that non-physician providers were
more likely to continue providing services than physicians (80.5% versus 53.3%).
Implementation of integrated care programs
In most programs studied, nurses and/or midwives were the main healthcare workers respon-
sible for cervical cancer screening and care coordination, with other cadre also engaged for
specialist functions such as supervision, pathology, and advanced care [4, 5, 22, 26, 29, 31, 35–
38, 40, 41]. Some studies describe the involvement of a wide range of professions and cadre
to ensure integration of services and follow-up of patients. For example, in western Kenya,
Khozaim et al. describe local nurses, gynecologists, oncology-gynecologists, laboratory staff,
pathologists, and lay people all being involved in the delivery of integrated care. Additionally,
Table 7. (Continued)
Study Objective Setting and sample
size
Study
design
Clinical & behavioral
outcomes
Process outcomes Risk of bias
Plotkin
2014
To provide a rough
measure of the success
of integration of HIV
testing into cervical
cancer screening, in
order to inform scale-up
of cervical cancer
screening services in
Tanzania.
21 health facilities
across 4 regions in
Tanzania.
n = 24,966 for CaCx
screening and 11,819
for HIV screening
Cross-
sectional
• Acceptability of testing:
94% (11,819) of those
offered accepted HIV
testing
• 5% (582) of those tested
learned for the first time
that they were HIV-
positive.
• The proportion of clients
offered HIV testing started
out high (averaging 86%
in 2011), and fell to 62% in
2012, and 55% in 2013.
• Reasons for declining
HIV test: most (96%) said
they ‘did not feel ready’ or
‘were afraid’, 3% said they
wanted to consult their
husband, while the
remaining 1% did not
specify a reason.
• Unavailability of HIV test
kits at the facility was the
most common reason for
a CaCx screening client
not to be offered an HIV
test (71% of 6,321 cases).
• Overall: unclear/
low
• selection: low diff
misclas: NA
• non-diff misclas:
unclear
• confounding: NA
Abbreviations: NA: not applicable, RRR: retrospective record review, CaCx: cervical cancer, diff misclas: differential misclassification, non-diff misclas: non-
differential misclassification
1 Risk of bias assessed as a randomized control trial for whether there is a difference between referral-only (before) and in-clinic treatment (after)
https://doi.org/10.1371/journal.pone.0181156.t007
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specialists from the USA were involved in continuous supervision of healthcare staff. Martin
et al. describe services in Guyana being shifted to non-physicians for scale-up of high-quality
cervical cancer prevention program nationally. Some studies recruited lay people for commu-
nity engagement activities, peer education, and to help with patient follow-up [24, 37, 40, 41].
Training was highlighted as a key feature in setting up programs of integration and expan-
sion of health services. For the most part, training was delivered by program partners as a
mixture of didactic classes and practical sessions [4, 5, 30–32, 35, 36, 41]. Some studies also
describe a process of on-site continual assessment and supervision [5, 32, 40]. Other programs
took a training of trainers approach; in Zambia, Mwanahamuntu et al. describe a train-the
trainer model where nurses served as educators for their peers. In Kenya, Khozaim et al.
describe key nurses undergoing training in cryotherapy and cervicography. These nurses then
trained and mentored other local Ministry of Health nurses who staffed the cervical cancer
screening services in their clinics. Only two studies found that programs used international
guidelines to support training and clinical practice. Odafe et al. used the practical manual on
visual screening for cervical neoplasia published by World Health Organization (WHO)
-International Agency for Research on Cancer (IARC) and Khozaim et al describe using
WHO guidelines on referrals and treatments. Other studies describe purposefully developing
guidelines, protocols and clinical algorithms as part of the program [26, 30, 34].
In addition to the training of health staff and need for clinical guidelines, other resources
were identified as necessary for implementation of integrated services, including infrastruc-
ture, equipment, and additional personnel along the care continuum, including sufficient
pathology support for timely access to diagnostics. Resources described include: material to
provide education and support to patients [5, 28, 34, 40]; staff to operate the referral system
[28, 30]; staff to coordinate integration[28]; forms or electronic medical records [4, 36]; and
medical and adequate infrastructure, including consistent electricity and water supply.
All studies utilized existing infrastructure as a platform for integrating services. Some used
infrastructure that had been previously established through existing technical assistance for
HIV programs [26, 30, 31, 35, 36, 40]. For example, Moon et al. describe a program in which
Friends in Global Health (FGH) utilized infrastructure that had been established through the
roll-out of Zambia’s PEPFAR-funded HIV care and treatment program. FGH supported the
introduction of cervical cancer screening by providing logistical and training support for
screening, including equipment purchase and distribution, minor facility renovations, in-ser-
vice training of national health system nurses and doctors, weekly clinical mentoring and on-
the-job training of nurses tasked to perform VIA and cryotherapy, and assistance with data
collection and analysis.
Discussion
In a systematic review of the literature to evaluate attempts to integrate HIV and cervical can-
cer services, we identified three models of integration: within clinic integration using existing
staff; coordination between co-located clinics/specialist; and complex programs of integration
involving coordination of many specialists/clinics. Overall, evidence suggests that the provi-
sion of integrated services was feasible, safe, and acceptable to both staff and women attending
the health facilities. Uptake of cervical cancer and HIV screening was high in all models
described, but loss to follow-up for cervical cancer treatment was a challenge in most studies.
Most studies described integration of cervical cancer screening using visual inspection
methods into existing HIV clinics, through training of existing staff in visual inspection tech-
niques, and treatment of minor to larger lesions. This model is potentially the most cost-effec-
tive, as it reduces the need for additional specialist staff and clinics and enables integration of
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both HIV and cervical cancer services in a single visit appointment. There is, however, a lack
of data available on the cost-effectiveness of these integration approaches.
Integration of screening and treatment into a single visit reduced loss to follow up. How-
ever, limited evidence is available on the best approach to providing these additional services
or on the long-term impacts of integration of services on patient outcomes and health system
strengthening. There was a limited number of studies that formally evaluated the integrated
services and most studies were set in Africa describing the introduction of new cervical cancer
services. Thus, a comprehensive evaluation and comparison of models of integration was not
possible. It was, however, noted that there were no notable differences in facilitators and barri-
ers between the models.
Barriers and facilitators to integration
All but one study described the introduction of new services as part of the approach to provid-
ing integrated care. In doing so, many barriers and facilitators to the introduction and integra-
tion of services are described (Table 6). That the reported facilitators and barriers were similar
in all models may be partly attributed to the fact that most studies were in Africa, in settings
with no or limited access to cervical cancer screening prior to integration of the service. For all
models, there was a need to train staff in new screening techniques, even in model two, which
described co-location of cervical cancer and HIV services. Many of the challenges documented
were not necessarily specifically related to the integration of services, but general health sys-
tems challenges experienced in many low-resourced settings [43].
Several distinctive facilitators where identified. The use of pre-existing infrastructure, such
as government-funded clinics, staff and services already targeting women living with HIV, [5,
26, 30, 34, 35, 37, 38, 40, 41], together with the use of HIV funded services, [35, 38] were key
facilitators to integration together with the single visit approach. Training of staff was another
key enabler for integrating the new services in all models, together with access to continuous
training and supervision for quality and sustainability [30, 32, 34, 35, 39–41]. Access to screen
and treat algorithms and guidelines were useful tools to support the training of health workers,
[30, 32, 40]. Access to electronic patient records [30, 38] facilitated quality by enabling tracking
of patients and results through the care pathways. Stakeholder engagement, not only with staff
but also with patients and communities, through talks, and community health promotion
campaigns, were other important aspects to sustain uptake [30, 38]. Peer-education, together
with counselling, were other important facilitators.
There were many barriers identified across the models, predominantly from the studies
set in low-resource settings, including logistical and chain management support [28, 29, 31,
32, 37, 40, 41] and access to consistent water, electricity, and equipment [5, 30, 35]. Despite
studies reporting staff satisfaction with the integrated services, increased staff workload [34,
35], shortage of staff [5, 30, 35], and high staff turnover [29, 32, 34, 35, 40, 41] were other key
barriers reported, for both within-clinic and co-located services. There were few studies
reviewing sustainability over time and in different settings, with some indicating variation
over time among different provides. Pfaendler et al., found that only a quarter of the staff ini-
tially trained in the single visit approach were still working at the sites when assessed and
four sites lacked a specialist gynecologist. Other barriers frequently reported highlighted the
need for strengthening of health systems across the care pathway when setting up a new ser-
vice, including ensuring sufficient laboratory capacity [29, 31, 34, 35, 40, 41] for timely
results and effective patient record systems [5, 30, 35]. Support for the overall clinic infra-
structure and human resources should, thus, be prioritized to improve the sustainability of
integrated care programs.
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Several studies also reported high loss to follow-up [37, 38]. Reasons reported for loss to fol-
low-up were similar across the studies; cost of treatment [36, 42] or transport [5, 29] together
with long journeys, long waiting times [42] and fear of HIV and cervical cancer diagnosis [29,
36] were the main patient related barriers reported. One study reported the need to consult
with the woman’s partner as another barrier. However, some studies found ways to reduce loss
to follow-up through mobile phone tracking systems [36] and appointment reminders [40] or
active follow-up by trained lay health workers [24, 40]. There is a need for a better understand-
ing of the extent to which women, facing many competing pressures, including day to day sur-
vival in many settings, must make trade-offs and, in this process, what value do they place on
an intervention where the cost is immediate but the benefits are a long time in the future. It is
well recognized that the characteristics of individuals can impact substantially on their time
preferences[44].
Study strengths and limitations
One of the strengths of our review was the inclusion of studies from a varied range of databases
and conference archives, which served to increase the number of papers from low- and mid-
dle-income countries. A limitation of our review is that most papers were descriptive, which
although providing insightful knowledge on strategies and approaches, constrained us from
assessing the effectiveness of programs. It is likely that other attempts have been made to inte-
grate HIV and cervical cancer services but have not been published. Most studies found were
from Africa, with limited studies from other geographical areas with different health systems.
Additionally, there may exist publication bias if studies with null or negative findings were less
likely to be published.
Implications for research
The evidence currently available on the integration of HIV and cervical cancer services, mostly
describes the introduction of new cervical cancer services into the HIV services setting rather
than evaluating integrated versus non-integrated services. Only five of the 23 studies reviewed
evaluated the effectiveness or sustainability of the integrated services. One of these five studies
compares ‘more’ with ‘less’ integration of services; reporting positive findings on acceptability
and effectiveness of the more integrated model [42]. The remaining four studies examine the
process of integration and the sustainability of the model of service delivery. Furthermore, the
outcomes explored across studies were mostly immediate clinical and process outcomes
(Table 3).
There is a need for high quality and robustly designed studies that seek to evaluate and
compare integration models (including comparison with non-integrated services) in terms of
their long-term impact on patient outcomes, including HIV disease progression and treatment
adherence, as well as cervical cancer morbidity and long-term outcomes, but also system-level
parameters, such as cost-effectiveness and sustainability. There is a need for evaluation to be
incorporated within the design and implementation of innovative programs that can establish
causality, including the different elements of the new program.
Implications for policy and service delivery
Despite the limited evidence available, descriptive studies on the introduction of cervical can-
cer services with HIV services have provided helpful insights into what has worked and what
challenges remain in expanding services for all women, but especially women living with HIV.
These findings highlight the need to incorporate strategies to reduce loss to follow-up. Ensur-
ing adequate infrastructure, human resource strengthening, and logistical support across care
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pathways is important to promote uptake of services. Many of the challenges described in the
studies are common in low-resource settings. When exploring the feasibility of integration of
health services, it is important to acknowledge that these services are embedded within a sys-
tem of care. Restructuring of health services should be considered as a complex intervention,
and should be researched and evaluated, including through improved routine monitoring and
using multidisciplinary and comprehensive approaches to understanding the wider-ranging
effects of differing approaches to providing health services. Furthermore, this comprehensive
approach should be extended beyond health services, through education at healthcare and
community level, including comprehensive sexual education, information campaigns about
the benefits of prevention, and addressing concerns about vaccination and screening services.
Moreover, involvement of community health workers as well as healthcare providers are
important to promote prevention and uptake of screening and treatment services for both cer-
vical cancer and HIV.
Conclusions
Several approaches to the integration of HIV and cervical cancer services have been described,
ranging from the training of existing staff in cervical cancer screening and treatment to com-
plex coordination of care between HIV and cervical cancer specialists and clinics to ensure
appropriate screening, treatment, and follow-up of patients. Integration programs are mostly
reported for low- and middle-income settings in sub-Saharan Africa, where HIV prevalence is
high and the provision of cervical cancer services remains low. Most studies were conducted
in partnership with national governments and led by NGOs.
Integration of HIV and cervical cancer screening and treatment is feasible and acceptable
to staff and patients and has the potential to improve uptake of screening for women living
with HIV. However, further research is needed to evaluate the impact of these models on treat-
ment adherence and long-term outcomes. The results also highlight a need to strengthen
health systems along care pathways, with an emphasis on staffing, training, and adequate sup-
ply of equipment.
The links between cervical cancer and HIV are a reminder that the needs of people living
with HIV are complex and often demand integrated solutions. Those settings with the highest
burden of HIV are often those with less integrated care services and health systems structured
around provision of care for acute conditions. The growing burden of chronic conditions,
both infectious and non-infectious, in resource-limited settings, will require further research
into how to most effectively and efficiently restructure health services to improve access and
quality of care.
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